| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2013 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 19 | Q2 2024 | 22.2% |
| Quince Therapeutics, Inc. (QNCX) | 19 | Q2 2024 | 43.2% |
| Vanguard Total Stock Market ETF (VTI) | 19 | Q2 2024 | 20.9% |
| ISHARES TR | 19 | Q2 2024 | 15.5% |
| SPDR Gold Trust ETF (GLD) | 19 | Q2 2024 | 8.4% |
| Alibaba Group Holding Limited (BABA) | 19 | Q2 2024 | 8.0% |
| VANGUARD TAX-MANAGED INTL FD | 19 | Q2 2024 | 2.7% |
| JD.com, Inc. (JD) | 19 | Q2 2024 | 3.3% |
| Vanguard Total World Stock ETF (VT) | 19 | Q2 2024 | 1.9% |
| SPDR S&P 500 ETF TR | 19 | Q2 2024 | 1.6% |
View EPIQ Capital Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Applied Molecular Transport Inc.Sold out | January 05, 2024 | 0 | 0.0% |
| Lucira Health, Inc.Sold out | December 22, 2022 | 0 | 0.0% |
View EPIQ Capital Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-09 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-09 |
| SC 13D/A | 2024-01-05 |
| 4 | 2023-12-29 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-11 |
| 13F-HR/A | 2023-02-14 |
View EPIQ Capital Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.